Patents Assigned to BIOCORRX PHARMACEUTICALS, INC.
  • Patent number: 11793801
    Abstract: The present disclosure is directed toward uses of compound 1 (or its stereoisomers) and compositions and/or dosage forms containing compound 1: or a pharmaceutically acceptable salt thereof. Some uses of Compound 1 and/or its stereoisomers include treating a variety of diseases and disorders, including pain, depression, and schizophrenia. In some embodiments, Compound 1 and/or its stereoisomers may be useful in the treatment of a substance use disorder while inducing fewer withdrawal symptoms than a standard-of-care opioid addiction treatment.
    Type: Grant
    Filed: February 9, 2022
    Date of Patent: October 24, 2023
    Assignee: BIOCORRX PHARMACEUTICALS, INC.
    Inventors: Brady J. Granier, Jeffrey M. Witkin